Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00413-6/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_acc24&_hsenc=p2ANqtz-8CjdaWAVpRFrwIqAlwR0i6QtU3ia88woWsGGl3PP51ETj_MF2WEoTyiCq3bnBkSIC4buUa2FLtpddU7AlaQwlGZhtarg&_hsmi=301365793&utm_content=301365793&utm_source=hs_email